Hepatitis B (HBV) is a major cause of global morbidity and mortality, and the leading cause
of liver cancer worldwide. Significant advances have recently been made toward the …

Background People with chronic hepatitis B (CHB) commonly experience social and self-
stigma. This study sought to understand the impacts of CHB-related stigma and a functional …

Chinese immigrants in Australia are overrepresented among people with chronic hepatitis B
virus (PWCHB) but experience poor access to healthcare. Given the historical discriminatory …

Objective Investigate the cascade of care for chronic hepatitis B (CHB) and estimate impacts
of increasing treatment uptake on attributable burden, according to jurisdiction. Methods A …

Despite the importance of trust in healthcare settings, there remains a paucity of evidence on
the role it plays in patient–provider relationships and healthcare outcomes among people …

Abstract Background In Australia, only 22% of people with chronic hepatitis B (CHB) are
clinically managed; and a national effort is engaging primary care workforce in providing …

Hepatitis B is a significant global health issue where the 296 million people estimated to live
with the infection risk liver disease or cancer without clinical intervention. The World Health …

Introduction Despite the availability of effective, subsidised hepatitis B treatment, linkage to
care and treatment rates remain very low globally. In Australia, specially trained primary care …

Introduction Despite the availability of effective, subsidised hepatitis B treatment, linkage to
care and treatment rates remain very low globally. In Australia, specially trained primary care …

Introduction Engagement of general practitioners (GPs) is essential to improving rates of
diagnosis and treatment of viral hepatitis, as traditional tertiary hospital-based models of …